KKR & Co. Inc. reports developments across its global investment business, including alternative asset management, capital markets activity and insurance solutions. Company news commonly covers operating results, fund and strategy activity, portfolio investments, co-investment vehicles, debt financing, and capital-structure updates.
KKR sponsors investment funds in private equity, credit and real assets, works with strategic partners that manage hedge fund platforms, and operates insurance subsidiaries that offer retirement, life and reinsurance products through Global Atlantic Financial Group. Recent company updates also reflect activity in technology growth, sports, sustainable infrastructure and insurance-related platforms.
FS KKR Capital (NYSE: FSK) reported third-quarter 2026 net investment income of $0.46 per share, up from the preceding quarter. Net investment income totaled $127 million, versus $159 million a year earlier. Earnings per share were $0.26, compared with a second-quarter loss of $0.13. Net realized and unrealized losses narrowed to $0.19 per share from $0.56 in the second quarter.
Net asset value fell to $18.28 per share from $18.30 at June 30. Investments on non-accrual status, where income recognition is suspended, declined to 3.4% of portfolio fair value from 3.8%. Debt to equity remained 127%, while net debt to equity rose to 125% from 122%. FSK repurchased approximately $69 million of shares during the quarter and another $17 million in October through October 30. The board declared a regular fourth-quarter distribution of $0.44 per common share and a $0.20 special distribution.
KKR (NYSE: KKR)-backed Sapphiros and Hildred-backed binx health have combined to form Onvaro, a diagnostics company focused on testing near patients. Funds managed by KKR, through its Health Care Strategic Growth strategy, Hildred and EQT Life Sciences are investing capital to support the combined company.
Onvaro brings together binx health’s FDA-cleared testing platform and national commercial network with Sapphiros’ development, manufacturing and product pipeline. Pipeline expansion remains subject to applicable regulatory clearances or approvals. Onvaro is developing technology designed to connect test results with care services. Mike Karsonovich, who led binx health, will serve as CEO; Sapphiros founder Namal Nawana will serve as lead director.
Rhythm Pharmaceuticals (Nasdaq: RYTM) amended its bivamelagon license with LG Chem, replacing portfolio royalties with a 1% rate and adding fixed payments. The rate replaces low-to-mid-single-digit royalties on global net sales of its MC4R portfolio, including setmelanotide, bivamelagon and RM-718, starting January 1, 2029, or first commercial bivamelagon sales, if earlier.
Rhythm owes $350 million in additional installments through September 2029. An additional milestone of up to $200 million is tied to $3 billion in annual portfolio net sales; existing milestones of up to $205 million remain. A five-year loan facility led by KKR’s HealthCare Royalty with Blackstone provides up to $750 million, including $500 million committed. An initial $250 million draw is expected at closing on November 6, 2026. Borrowings carry SOFR, a benchmark interest rate, plus 4.60%, with no equity component or scheduled principal repayments before maturity.
HASI (HASI) and KKR (KKR) announced that their co-investment vehicle, CarbonCount Holdings 1, priced $400 million of senior unsecured notes.
The privately offered, fixed-rate amortizing notes carry a 7.09% weighted-average coupon and a 20-year final maturity. Net proceeds are expected to be approximately $396 million after estimated offering expenses. CarbonCount Holdings 1 intends to use the proceeds to acquire or invest in new or existing sustainable infrastructure projects, in whole or in part. This is the vehicle’s third issuance of senior notes.
Alexandria Real Estate Equities (NYSE: ARE) received a $475 million joint venture investment from capital accounts advised by KKR (NYSE: KKR).
KKR acquired a 49% noncontrolling equity interest in Alexandria’s Campus Point investment entity, representing approximately 28.5% indirect ownership in the underlying joint venture. Campus Point is a nearly 2 million-square-foot life science campus in San Diego’s University Town Center submarket.
The investment provides Alexandria with flexible, long-term capital to support continued development, leasing and property enhancements. Alexandria will retain control of the underlying joint venture and continue overseeing operations and development. Long-term leases with corporate and institutional tenants account for approximately 98% of campus rental revenue.
KKR (NYSE: KKR) appointed Brian J. Lee to its Board of Directors, effective October 26, 2026. His appointment brings the number of independent directors to eight out of twelve Board seats. Lee is the former Chief Risk Officer of The Goldman Sachs Group.
DentalXChange appointed Scott Hampel president to lead its product, operations, and engineering organizations under CEO Paul Kaiser. Hampel brings more than 25 years of healthcare technology leadership and most recently served as president of Mosai, formerly Medalogix.
Kaiser remains CEO, with a focus on corporate strategy, growth, and partnerships. DentalXChange expects consolidating the three functions under Hampel to speed delivery of new solutions. Investor KKR (KKR) described the appointment as supporting its plan to accelerate product development and scalable growth.
KKR (KKR) agreed to acquire IEP Technologies and Newson Gale, representing the majority of HOERBIGER’s Safety Business Unit. The transaction covers HOERBIGER’s Explosion Protection and Static Control segments. IEP provides industrial explosion protection systems, while Newson Gale supplies static grounding and bonding solutions. KKR is investing through its Global Impact Strategy; financial terms were not disclosed.
Closing is expected in the first quarter of 2027, subject to regulatory approvals and customary closing conditions. KKR plans to support new capabilities, expansion opportunities and a broad-based employee ownership program after closing. HOERBIGER will retain its Engine & Generators segment and integrate it into its Compression Division.
KKR (NYSE: KKR) announced that Chief Financial Officer Robert H. Lewin will present at the BMO Financials Conference on November 10, 2026. The presentation is scheduled for 8:00 AM ET. A live webcast will be available through KKR’s Investor Center website, with a replay available shortly after the event.
KKR (NYSE: KKR) agreed to sell Infinity Transportation to Ares funds for an enterprise value of approximately $2.9 billion. The buyers are Ares Infrastructure Equity and Ares Insurance Solutions funds. The transaction is expected to close in the first quarter of 2027, subject to regulatory approvals and customary closing conditions.
Infinity owns and manages approximately 50,000 railcars leased to more than 350 unique lessees across the United States, Canada and Mexico. KKR’s wholly owned subsidiary Global Atlantic has invested in Infinity since 2016. Since 2021, Infinity established a standalone operating platform and expanded its fleet with KKR’s support, increasing book value by 150%.